Your browser doesn't support javascript.
loading
Safety and immunogenicity of BK-SE36/CpG malaria vaccine in healthy Burkinabe adults and children: a phase 1b randomised, controlled, double-blinded, age de-escalation trial.
Ouédraogo, Alphonse; Bougouma, Edith Christiane; Palacpac, Nirianne Marie Q; Houard, Sophie; Nebie, Issa; Sawadogo, Jean; Berges, Gloria D; Soulama, Issiaka; Diarra, Amidou; Hien, Denise; Ouedraogo, Amidou Z; Konaté, Amadou T; Kouanda, Seni; Myoui, Akira; Ezoe, Sachiko; Ishii, Ken J; Sato, Takanobu; D'Alessio, Flavia; Leroy, Odile; Tiono, Alfred B; Cousens, Simon; Horii, Toshihiro; Sirima, Sodiomon B.
Affiliation
  • Ouédraogo A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
  • Bougouma EC; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
  • Palacpac NMQ; Department of Malaria Vaccine Development, Research Institute for Microbial Diseases, Osaka University, Suita, Japan.
  • Houard S; European Vaccine Initiative (EVI), Universitäts Klinikum Heidelberg, Heidelberg, Germany.
  • Nebie I; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
  • Sawadogo J; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
  • Berges GD; Hôpital Protestant Schiphra, Ouagadougou, Burkina Faso.
  • Soulama I; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
  • Diarra A; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
  • Hien D; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
  • Ouedraogo AZ; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
  • Konaté AT; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
  • Kouanda S; Institut de Recherche en Sciences de la Santé, Ouagadougou, Burkina Faso.
  • Myoui A; Medical Center for Translational Research, Osaka University Hospital, Suita, Japan.
  • Ezoe S; Medical Center for Translational Research, Osaka University Hospital, Suita, Japan.
  • Ishii KJ; Department of Space Infection Control, Graduate School of Medicine, Division of Health Sciences, Osaka University, Osaka, Japan.
  • Sato T; Center for Vaccine and Adjuvant Research, National Institutes of Biomedical Innovation, Health and Nutrition, Ibaraki, Japan.
  • D'Alessio F; Laboratory of Vaccine Science, Immunology Frontier Research Center, Osaka University, Suita, Japan.
  • Leroy O; Division of Vaccine Science, Department of Microbiology and Immunology, The Institute of Medical Science, The University of Tokyo, Tokyo, Japan.
  • Tiono AB; Research and Development Division, Nobelpharma Co., Ltd., Tokyo, Japan.
  • Cousens S; European Vaccine Initiative (EVI), Universitäts Klinikum Heidelberg, Heidelberg, Germany.
  • Horii T; European Vaccine Initiative (EVI), Universitäts Klinikum Heidelberg, Heidelberg, Germany.
  • Sirima SB; Groupe de Recherche Action en Santé (GRAS), Ouagadougou, Burkina Faso.
Front Immunol ; 14: 1267372, 2023.
Article in En | MEDLINE | ID: mdl-37908361
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Malaria, Falciparum / Malaria Vaccines / Malaria Limits: Adult / Child / Child, preschool / Humans / Infant / Male / Middle aged Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Malaria, Falciparum / Malaria Vaccines / Malaria Limits: Adult / Child / Child, preschool / Humans / Infant / Male / Middle aged Language: En Journal: Front Immunol Year: 2023 Document type: Article Affiliation country: Country of publication: